Your browser doesn't support javascript.
loading
Using high-throughput sequencing for investigating intra-host hepatitis C evolution over long retrospective periods.
Caporossi, A; Kulkarni, O; Blum, Mgb; Leroy, V; Morand, P; Larrat, S; François, O.
Afiliação
  • Caporossi A; Université Grenoble Alpes, TIMC-IMAG, CNRS UMR, 5525 Grenoble, France; Pôle Santé Publique, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France. Electronic address: acaporossi@chu-grenoble.fr.
  • Kulkarni O; Université Grenoble Alpes, TIMC-IMAG, CNRS UMR, 5525 Grenoble, France.
  • Blum M; Université Grenoble Alpes, TIMC-IMAG, CNRS UMR, 5525 Grenoble, France.
  • Leroy V; Clinique d'Hépatologie, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
  • Morand P; Institut de Biologie Structurale, UMR2075 CEA-CNRS-UGA, Grenoble, France; Laboratoire de Virologie, Pôle Biologie, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
  • Larrat S; Institut de Biologie Structurale, UMR2075 CEA-CNRS-UGA, Grenoble, France; Laboratoire de Virologie, Pôle Biologie, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
  • François O; Université Grenoble Alpes, TIMC-IMAG, CNRS UMR, 5525 Grenoble, France.
Infect Genet Evol ; 67: 136-144, 2019 01.
Article em En | MEDLINE | ID: mdl-30395998
ABSTRACT
Collections of biological samples held by hospitals represent invaluable resources for conducting retrospective evolutionary studies of chronic infections. Using high-throughput sequencing, those collections permit analysis of within-host genetic diversity over long follow-up periods, and allow a better understanding of resistance to treatment regimes during disease evolution. Here, we studied the evolution of hepatitis C virus (HCV) populations in two patients with an absence of response to dual therapies. We implemented amplicon sequencing to survey genomic variation at the Core and NS5B regions of HCV over a period of 13 years from blood samples obtained at multiple time points. We observed mixed infection by multiple HCV genotypes in both patients. Genetic heterogeneity and sample composition analysis provided information about the changes in viral population over the course of clinical treatment, with NS5B experiencing an increase in diversity after treatment initiation. Secondary infections were estimated to predate treatment year, and our results pointed towards diversifying selection occurring post-treatment, acting on standing genomic variation and maintaining high genetic heterogeneity during infection. For these two patients infected with multiple HCV genotypes, the maintenance of viral diversity was explained with the hypothesis of soft selective sweep started at the same time as antiviral treatment was initiated.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Hepatite C / Hepacivirus / Evolução Molecular / Interações Hospedeiro-Patógeno / Sequenciamento de Nucleotídeos em Larga Escala Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Hepatite C / Hepacivirus / Evolução Molecular / Interações Hospedeiro-Patógeno / Sequenciamento de Nucleotídeos em Larga Escala Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article